Literature DB >> 9065648

Alteration of p53 gene structure and function in laryngeal squamous cell cancer.

W Golusinski1, J Olofsson, Z Szmeja, K Szyfter, W Szyfter, W Biczysko, K Hemminki.   

Abstract

The p53 gene is known as an anti-oncogene that manifests its function by controlling the cell cycle and is responsible for apoptosis of cells with unrepaired DNA. An accelerated p53 protein synthesis is the first response of a cell following DNA damage. However, mutations of the p53 gene can disturb protein synthesis or may be responsible for synthesis of a changed protein unable to control the cell cycle. Laryngeal tissue specimens from 120 patients were tested by immunohistopathological staining to detect mutated wild-type p53 protein. It was found that p53-positive specimens correlated with TNM staging and histopathological grading. Another indication of entering the cell cycle and undertaking an active proliferation by laryngeal cells was shown by detection of proliferating cell nuclear antigen (PCNA) and Ki67 nuclear antigen, which appeared in proliferating cells (late G1, S-G2 and M phase), but was absent in resting cells. Scoring of the staining for p53 protein, PCNA and Ki67 correlated with each other. DNA from 40 specimens was then isolated, amplified by polymerase chain reaction and analysed by single-strand conformation polymorphism and DNA sequencing for mutation in the p53 gene. Fifteen DNA samples were found to be positive, while mutations were detected in exons 5-8 in 13 samples. The majority of mutations were found in tissue specimens from T3 and T4 tumors. A possible explanation is almost half was attributable to genotoxic effects of tobacco smoking. Changes in the p53 gene and its products may also reflect early changes in laryngeal carcinogenesis and be of prognostic value.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9065648     DOI: 10.1007/bf02439744

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  20 in total

1.  High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx.

Authors:  R Maestro; R Dolcetti; D Gasparotto; C Doglioni; S Pelucchi; L Barzan; E Grandi; M Boiocchi
Journal:  Oncogene       Date:  1992-06       Impact factor: 9.867

2.  The presence of p53 protein in relation to Ki-67 as cellular proliferation marker in head and neck squamous cell carcinoma and adjacent dysplastic mucosa.

Authors:  P J Slootweg; R Koole; G J Hordijk
Journal:  Eur J Cancer B Oral Oncol       Date:  1994

3.  p53 expression and cell proliferation in squamous cell carcinomas of the head and neck.

Authors:  K Nylander; R Stenling; H Gustafsson; B Zackrisson; G Roos
Journal:  Cancer       Date:  1995-01-01       Impact factor: 6.860

4.  p53 over-expression is an early event in the development of human squamous-cell carcinoma of the larynx: genetic and prognostic implications.

Authors:  R Dolcetti; C Doglioni; R Maestro; D Gasparotto; L Barzan; A Pastore; M Romanelli; M Boiocchi
Journal:  Int J Cancer       Date:  1992-09-09       Impact factor: 7.396

5.  p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines.

Authors:  D G Brachman; M Beckett; D Graves; D Haraf; E Vokes; R R Weichselbaum
Journal:  Cancer Res       Date:  1993-08-15       Impact factor: 12.701

Review 6.  The role of the p53 tumor suppressor gene in squamous cell carcinoma of the head and neck.

Authors:  J K Field; Z P Pavelic; D A Spandidos; P J Stambrook; A S Jones; J L Gluckman
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1993-10

7.  p53, retinoblastoma, and human papillomavirus in squamous cell carcinoma and adjacent normal mucosa of the upper aerodigestive tract.

Authors:  N K Lee; Y W Ye; J Chen; X Li; P G Waber; P D Nisen
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1993-10

8.  Frequent p53 mutations in head and neck cancer.

Authors:  K D Somers; M A Merrick; M E Lopez; L S Incognito; G L Schechter; G Casey
Journal:  Cancer Res       Date:  1992-11-01       Impact factor: 12.701

9.  Over-expression of p53 protein in human laryngeal carcinoma.

Authors:  K Anwar; K Nakakuki; H Imai; H Naiki; M Inuzuka
Journal:  Int J Cancer       Date:  1993-04-01       Impact factor: 7.396

10.  Nuclear DNA content, proliferating-cell nuclear antigen (PCNA) and p53 immunostaining in predicting progression of laryngeal cancer in situ lesions.

Authors:  E Munck-Wikland; S Edström; E Jungmark; R Kuylenstierna; J Lindholm; G Auer
Journal:  Int J Cancer       Date:  1994-01-02       Impact factor: 7.396

View more
  1 in total

1.  p53, Ki67 and cyclin D1 as prognosticators of lymph node metastases in laryngeal carcinoma.

Authors:  D Mielcarek-Kuchta; J Olofsson; W Golusinski
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-10-09       Impact factor: 2.503

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.